Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Eva Vandeplassche, Sarah Tavernier, Tom Coenye, Aurélie Crabbé. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens. Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019

Member's Comments

No comment yet.

Related content which might interest you: Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Managing antimicrobial resistance in cystic fibrosis Source: International Congress 2014 – ERS/Lancet and Lancet Respiratory Medicine joint session: complicating infections in respiratory disease and critical care Year: 2014 Antibiotic treatment of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 188-202 Year: 2014 Effect of microbial communities on antimicrobial drug efficacy and host inflammation in Cystic Fibrosis Source: ERS Lung Science Conference 2019 Year: 2019 Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics Source: Eur Respir J 2014; 44: 922-930 Year: 2014 Susceptibility of problem respiratory pathogens to levofloxacin in cystic fibrosis (CF) Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002 Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis Source: ERJ Open Res, 6 (3) 00115-2020; 10.1183/23120541.00115-2020 Year: 2020 Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 Effect of long term treatment with azithromycin on clinical status and lung function parameters in cystic fibrosis patients colonised by pseudomonas aeruginosa Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Temporal progression of fungal microbiota in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Fungal colonization in interstitial lung diseases Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Management of the CF lung pathogens Source: ERS course 2015 Year: 2015 The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects Source: Eur Respir Rev, 30 (161) 210055; 10.1183/16000617.0055-2021 Year: 2021 Current concepts: host–pathogen interactions in cystic fibrosis airways disease Source: Eur Respir Rev 2014; 23: 320-332 Year: 2014 Update on management of lung infection in cystic fibrosis Source: Virtual Congress 2020 – Updates in cystic fibrosis Year: 2020 What damages the cystic fibrosis lung epithelium: host or microbe? Source: Virtual Congress 2021 – Innate immunity and lung epithelial repair: what really happens? Year: 2021 Emerging pathogens in cystic fibrosis Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases Year: 2019